older man looking into the camera

older woman looking into the camera

COMBINING
TO CURE^®

People and science are a beautiful combination.

Arcus is at the forefront of designing combination therapies, with best-in-class potential, in our relentless pursuit of cures for cancer.

Featured

Arcus News: Arcus Announces that New Data Support Best-in-Class Potential for Investigational Molecule Casdatifan, a HIF-2α Inhibitor, in Patients with Metastatic Kidney Cancer

Press Release: Arcus Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor

Arcus News: Arcus Announces that New Data Support Best-in-Class Potential for Investigational Molecule Casdatifan, a HIF-2α Inhibitor, in Patients with Metastatic Kidney Cancer

Press Release: Arcus Retains Rights to Casdatifan, a Potential Best-in-Class HIF-2a Inhibitor

We are combining

DISCOVERY CAPABILITIES

Producing differentiated small molecules and antibodies designed to optimize combinability

ACCELERATED DEVELOPMENT

Guided by specific biologic mechanisms of cancer, to advance combination therapies from Phase 1 studies through commercialization

PARTNERSHIP WITH THE CANCER COMMUNITY

To facilitate participation in our global clinical trials and bring new medicines to patients faster

Joining forces to defeat cancer.
This is COMBINING TO CURE

Explore More